📣 Our partners at Swing Therapeutics, Inc. just made a huge leap forward for managing chronic pain caused by fibromyalgia! Last week, they announced the publication of data in The Lancet from their Phase 3 trial of Stanza, a new behavioral therapy for fibromyalgia treatment. Stanza is truly groundbreaking. It delivers acceptance and commitment therapy (ACT), a type of cognitive behavioral therapy that’s been validated as an effective treatment for fibromyalgia, but that’s largely inaccessible to patients. Now via Stanza, patients can access ACT directly from their smartphone, and the results are overwhelmingly positive. A multi-center, randomized controlled trial clinically validated Stanza’s benefits, including improvements in well-being, severity, and major symptoms. It’s also the largest study on an FDA-cleared medical device for fibromyalgia that has ever been undertaken. ⭐ We’re proud to partner with Swing on this journey to create more accessible treatment options and healthier lives for people living with chronic pain! Dive into findings from the pivotal Phase 3 study on Stanza here: https://bit.ly/4bKo2H6
Medrio
Software Development
San Francisco, CA 9,605 followers
Powering your research potential.
About us
At Medrio, we're fueled by an ambitious vision: to improve 100 million lives by enabling secure, reliable, and efficient clinical trials. Since 2005, we have cultivated a thriving network of individuals who share a common goal of making a positive impact - including our dedicated team of Medrians, valued customers, and trusted partners. Our eClinical solutions are flexible and configurable to meet the needs of any clinical trial - from traditional to fully decentralized. Our solutions are easy to learn, easy to use, scalable and connected through one unified platform, providing unmatched efficiency, reliability, clarity and sophistication. As an employer, our core values are rooted in a customer-first approach, an A-player mindset, and a sprinkle of quirkiness to keep things fun and interesting. We are dedicated to powering the potential of clinical research - and we invite you to be a part of our mission. Visit our website to learn more, request a demo, or apply to join our team.
- Website
-
http://www.medrio.com
External link for Medrio
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- San Francisco, CA
- Type
- Privately Held
- Founded
- 2005
- Specialties
- Electronic Data Capture (EDC), eClinical, Electronic Case Report Forms (eCRF), Electronic Patient-Reported Outcomes (ePRO), Data Management, Clinical Research Organization (CRO), Phase 1-4, patient centricity, eCOA, eSource, Clinical Trials , Easy-to-use, RTSM, Randomization and Trial Supply Management, Electronic Consent (eConsent), Electronic Data Capture (EDC), and Clinical Data Management
Locations
-
Primary
345 California Street
Suite 600
San Francisco, CA 94104, US
-
1 St Katharine's Way
London, England E1W 1, GB
-
2nd floor
Sai Apex 201, Viman Nagar,
Datta Mandir Chowk, Pune 411014, IN
Employees at Medrio
Updates
-
Why choose a CDMS/EDC partner that prioritizes data accessibility? Whether you’re working alone or with a small team, oversight can help you monitor progress and identify actions to stay on track as your research operations grow. 🔻 See at-a-glance below what features and functionalities you should look for in a CDMS/EDC to support real-time, data-driven decisions. Read the full eBook on strategic scaling for emerging companies here: https://bit.ly/3XjTrN5 #EDC #CDMS #ClinicalTrials #ClinicalDataManagement #DataQuality
-
📣 ICYMI📣 July's Resource Roundup includes: 📖 How to set up your CDMS/EDC to overcome staffing challenges and grow with you 📊 What other small biopharma orgs and CROs think about the latest eClinical trends 🏥 Meeting the regulatory push for Real-Time Oncology Review (RTOR) while executing mid-study changes Learn more here: https://bit.ly/3W2xbVT #EDC #CDMS #Oncology #Biotech #CRO #DataQuality #ClinicalDataManagement #ClinicalTrials
-
Take the first step towards mastering mid-study updates with our next EDC/CDMS demo webinar! Protocol amendments are the largest cause of unplanned delays and unbudgeted costs in a clinical trial. In fact, more than 75% of studies in Phase I and II are impacted by them. Be prepared when mid-study changes affect your operations and see how Medrio handles this common challenge. Register today to save your seat! #CDMS #EDC #ClinicalTrials #ClinicalDataManagement
This content isn’t available here
Access this content and more in the LinkedIn app
-
🔊Advocacy from patients themselves is often a major factor driving innovation in clinical research–especially when it comes to gene therapy trials. Discover the remarkable stories of gene therapy research advocates, and how their voices are inspiring life-saving change in our blog: https://bit.ly/4cCIivM
-
🔑 Implementing #ePRO sets off a chain reaction for participants and sponsors. ePRO is more convenient for participants to use than traditional paper methods. ➡️ Convenience leads to better compliance and more consistent data entry. ➡️ Compliance and consistency means sponsors get complete, accurate data in real time while adhering to protocol schedules. Curious about the advantages of ePRO? Read our paper vs. ePRO guide, featuring Medrio’s VP of eClinical Solutions and Consulting, Melissa Newara: https://bit.ly/3xNUVoy #PatientCentricity #DataQuality #ClinicalTrials #ClinicalDataManagement
-
📩 The results of our latest survey with BioPharma Dive are in! Emerging #biopharma, #biotech, and #CRO decisions-makers seem most excited about improvements in data reliability. They also reported data reliability as a top benefit of a technology-backed future. See what aspects of clinical trial technology are working for biopharma and CRO decision-makers, and what aspects could use optimization. Read the survey report: https://bit.ly/4bYxKGU
-
🗓️ The July Edition of Medrio's Resource Roundup is here! Look back at Medrio's most popular resources from the past month to learn: ✅ How emerging biotech and CRO organizations are using eClinical technology in their clinical trials and other trends from our survey report. ✅ Why proactive guidance is so important for emerging organizations as they look to overcome staffing challenges and navigate growth phases. ✅ How early-phase oncology sponsors can benefit from a fully integrated CDMS/EDC solution, from supporting mid-study changes to meeting the push for Real-Time Oncology Review (RTOR). #EDC #CDMS #Oncology #Biotech #CRO #DataQuality #ClinicalDataManagement #ClinicalTrials
[July '24] Resource Roundup
Medrio on LinkedIn
-
📈 As your clinical trials grow, so do regulatory, resource, and time pressures that can prevent you from scaling efficiently. Our webinar featuring Nicole Latimer and Roche Diagnostics' Khone Saysana and Walter S. dives into strategic eClinical solutions that can help you scale with ease. Watch it on-demand today: https://bit.ly/45NQJS2
-
Don’t risk decision-making delays in your clinical trials! Make the switch to ePRO for: 📲 Immediate access to patient-reported outcome data 📨 Less data reconciliation and manual entry ⏰ Prompt identification of issues and missing data Discover how ePRO can transform your clinical data collection processes with our guide: https://bit.ly/3XJ0yyQ #ePRO #DataQuality #ClinicalDataManagement #PatientCentricity